{
    "organizations": [],
    "uuid": "784e849e3906b72a215a4dfb8097cdb06ec866d8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genmark-diagnostics-reports-first/brief-genmark-diagnostics-reports-first-quarter-2018-results-idUSASC09YQO",
    "ord_in_thread": 0,
    "title": "BRIEF-Genmark Diagnostics Reports First Quarter 2018 Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - GenMark Diagnostics Inc:\n* Q1 LOSS PER SHARE $0.21 * Q1 REVENUE $20.6 MILLION VERSUS I/B/E/S VIEW $17.1 MILLION\n* SEES FY 2018 REVENUE $68 MILLION TO $72 MILLION * Q1 EARNINGS PER SHARE VIEW $-0.22 — THOMSON REUTERS I/B/E/S\n* GENMARK IS RECONFIRMING PRIOR 2018 REVENUE GUIDANCE OF $68 TO $72 MILLION\n* FULL YEAR 2018 GROSS MARGIN IS EXPECTED TO BE IN 30% RANGE\n* FY2018 REVENUE VIEW $69.7 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-02T05:12:00.000+03:00",
    "crawled": "2018-05-02T16:06:16.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "genmark",
        "diagnostics",
        "inc",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "genmark",
        "reconfirming",
        "prior",
        "revenue",
        "guidance",
        "million",
        "full",
        "year",
        "gross",
        "margin",
        "expected",
        "range",
        "fy2018",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}